Compounded Tirzepatide Tablets (ODT)

What this is

A compounded orally disintegrating tablet for weight management that a licensed provider may prescribe after reviewing your health history, current medications and goals. Your provider decides whether it is appropriate and gives you dosing directions. Prepared by a state-licensed pharmacy for you individually. Compounded tablet forms have not been evaluated by the FDA for safety or effectiveness.

How it works

Compounded tirzepatide orally disintegrating tablet, taken as directed by your provider

Who it may be appropriate for

Adults whose licensed provider determines treatment is appropriate after reviewing their health history.

Key risks

Do not use if you or a family member have had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are pregnant, planning pregnancy or breastfeeding. Tell your provider if you have had pancreatitis, gallbladder disease, kidney problems or diabetic eye disease, or take insulin or a sulfonylurea (risk of low blood sugar). Common side effects include nausea, vomiting, diarrhea, constipation, stomach pain and decreased appetite. Seek care right away for severe stomach pain, a lump or swelling in the neck, trouble swallowing, or signs of an allergic reaction.

Who should not use it

• Anyone with a personal or family history of medullary thyroid cancer or MEN2
• Anyone pregnant, breastfeeding or trying to conceive
• Anyone with a history of pancreatitis or type 1 diabetes

Common side effects

• Nausea
• Vomiting
• Diarrhea or constipation
• Stomach pain
• Reduced appetite

When to seek care

• Severe stomach pain that does not go away, with or without vomiting
• Signs of an allergic reaction
• A lump or swelling in the neck, or trouble swallowing

Interactions

• Insulin and sulfonylureas (higher risk of low blood sugar)
• Oral medicines whose absorption may change with slower digestion
• Other weight medicines